Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9718827
Compounds useful as inhibitors of ATR kinase
granted patentUS 9714244
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors
granted patentUS 9708296
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted patentUS 9707221
Methods of treating cancer patients with farnesyltransferase inhibitors
granted patentUS 9707215
Inhibitors of hepatitis C virus polymerase
granted patentUS 9701674
Substituted pyrazines as ATR kinase inhibitors
granted patentUS 9701661
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric ox
granted patentUS 9694071
Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
granted patentUS 9693999
Small molecule RNase inhibitors and methods of use
granted patentUS 9688722
Substrates and inhibitors of prolyl oligopeptidase and methods of use
granted patentUS 9688710
Inhibitors of sodium glucose cotransporter 1
granted patentUS 9688697
RNA polymerase I inhibitors and uses thereof
granted patentUS 9688692
Neprilysin inhibitors
granted patentUS 9688616
Neprilysin inhibitors
granted patentUS 9687489
Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors
granted patentUS 9683002
Neprilysin inhibitors
granted patentUS 9682982
Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of th
granted patentUS 9682976
Protein kinase C inhibitors and uses thereof
granted patentUS 9682052
Neprilysin inhibitors
granted patentUS 9677143
Compositions and methods for the identification of inhibitors of retroviral infection
granted patentUS 9676802
Hepatitis C virus inhibitors
granted patentUS 9676759
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
granted patentUS 9675697
BET bromodomain inhibitors and therapeutic methods using the same
granted patentUS 9670213
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
granted